Cargando…
The Impact of Chemotherapy after Pediatric Malignancy on Humoral Immunity to Vaccine-Preventable Diseases
BACKGROUND/AIM: The antibody titer of vaccine-preventable diseases in pediatric patients who underwent chemotherapy was assessed in order to evaluate the seroprotection after treatment and the feasibility and the efficacy of a policy of revaccination. METHODS: Serum antibody titers of 55 patients fo...
Autores principales: | Garonzi, Chiara, Balter, Rita, Tridello, Gloria, Pegoraro, Anna, Pegoraro, Manuela, Pacenti, Monia, Scattolo, Novella, Cesaro, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059740/ https://www.ncbi.nlm.nih.gov/pubmed/32180909 http://dx.doi.org/10.4084/MJHID.2020.014 |
Ejemplares similares
-
Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
por: Devilli, Lara, et al.
Publicado: (2021) -
Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy
por: Licciardello, Maria, et al.
Publicado: (2011) -
A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant
por: Cesaro, Simone, et al.
Publicado: (2013) -
The Use of Splenectomy to Manage Platelet Transfusion Refractoriness due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation
por: Mauro, Margherita, et al.
Publicado: (2016) -
Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology–Oncology Unit: A 10-Year Study
por: Mattei, Davide, et al.
Publicado: (2022)